LB Pharmaceuticals Inc Common Stock (LBRX) NASDAQ
24.93
+0.265(+1.07%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
LB Pharmaceuticals Inc Common Stock
Address
One Pennsylvania Plaza
New York, NY 10119
United States of America (the)
Phone
212 605 0300
Website
Sector
Healthcare
Industry
Biotechnology
Employees
16
First IPO Date
September 11, 2025
Key Executives
| Name | Title | Pay | Year Born |
| Heather D. Turner | Chief Executive Officer & Director | 426,833 | 1973 |
| Zachary Prensky | Co-founder, Advisor to the Chief Executive Officer & Director | 1.51M | 1976 |
| Anna Eramo | Chief Medical Officer | 651,300 | 1974 |
| James Rawls | Senior Vice President of Regulatory Affairs | 0 | N/A |
| Richard Silva | Senior Vice President of Technical Operations | 0 | 1967 |
| Soffer | Chief Business Officer | 0 | 1977 |
| Marc L. Panoff | Senior Vice President of Finance | 0 | 1970 |
| Kaya Pai Panandiker | Chief Commercial Officer | 0 | N/A |
Description
Clinical‑stage biopharmaceutical company developing novel therapies for neuropsychiatric diseases (e.g. schizophrenia, bipolar depression). Lead candidate is LB‑102, a methylated derivative of amisulpride.
